Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non–Small-Cell Lung Cancer (NADIM phase II trial)
Mariano Provencio, Roberto Serna‐Blasco, Ernest Nadal, Amelia Insa, M.R. García-Campelo, Joaquin Casal Rubio and 23 more
- Rank
- 27 of 548
- Percentile
- top 5%
- Where
- Journal of Clinical Oncology, 2022
- Citations
- 353
From the 2022 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.